Navarra SV Oxford University Press is a department of the University of Oxford. Mina R Different definitions of disease activity according to the PGA instrument. The aim of this systematic literature review is to describe and analyse the . The responsiveness of the PGA is the ability to detect worthwhile variations in disease activity over time, measuring worsening or improvements in SLE disease status. Help us improve CareerBuilder by providing feedback about this job: Report this job Job ID: 2281236908. Liang MH Physician Global Assessment International - ScienceDirect The PGA is a well accepted and commonly used scale for evaluating treatment response in clinical trials both in adults and children. Methods Definition: At least a 20%, 40%, 50%, or 70% improvement and an absolute improvement of at least 1 unit on a scale of 1-10 in at least three of the following criteria: patient global assessment; pain; function (BASFI); and. Importance: In dermatology, the development of objective, standardized quality measures that can be used in a clinical setting is important to be able to respond to the needs of payers and credentialing and licensure bodies and to demonstrate dermatologic value. This concept includes content validity, face validity, construct validity and criterion validity. , Aggarwal R . , Kandane-Rathnayake RK Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual, The systemic lupus activity measure-revised, the Mexican systemic lupus erythematosus disease activity index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus, Small changes in outpatients lupus activity are better detected by clinical instruments than by laboratory tests, Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50, Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation, Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months, Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial, Psychological distress and changes in the activity of systemic lupus erythematosus, The rating scale preference measure as an evaluative measure in systemic lupus erythematosus, Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus, Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months, Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus, Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006, Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale, Autoantibodies against albumin in patients with systemic lupus erythematosus, Association of depression with socioeconomic status, anticardiolipin antibodies, and organ damage in patients with systemic lupus erythematosus: results from the KORNET registry, Placebo-controlled randomized clinical trial of fish oils impact on fatigue, quality of life, and disease activity in systemic lupus erythematosus, Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus, Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis, Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity, Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus, Turkish LupusPRO: cross-cultural validation study for lupus, Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines, Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial, Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity, The TNF locus is altered in monocytes from patients with systemic lupus erythematosus, Effect of pregnancy on disease flares in patients with systemic lupus erythematosus, Frequency of lupus flare in pregnancy: the Hopkins Lupus Pregnancy Center experience, Morbidity of systemic lupus erythematosus: role of race and socioeconomic status, Classification and definition of major flares in SLE clinical trials, Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study, COSMIN guideline for systematic reviews of patient-reported outcome measures, Validity and reliability in social science research, Understanding the minimum clinically important difference: a review of concepts and methods, Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research, Minimum important difference between patients with rheumatoid arthritis: the patients perspective, Responsiveness and sensitivity to change of SLE disease activity measures, The Author(s) 2020. , Kraag GR et al. , Tetzlaff J et al. Physician's Global Assessment in Psoriatic Arthritis: A Multicenter The quantification of reliability is expressed by a correlation coefficient. All versions are validated and used by lupus researchers for clinical and research purposes. Bethesda, MD 20894, Web Policies The pooled correlation coefficient (95% CI) is given both for the fixed effects model and the random effects model. , Weisman MH. Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index, Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial, Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus, Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity, Characterization of clinical photosensitivity in cutaneous lupus erythematosus, Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus, Depressive symptoms and associated factors in systemic lupus erythematosus, Validation of the Portuguese simple measure of impact of lupus erythematosus in youngsters (SMILEY) in Brazil, Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers, Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus, An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA, Noncalcified coronary plaque in systemic lupus erythematosus, Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus, Validity and reliability of lupus activity measures in the routine clinic setting, Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Faculty Publications: Feb. 23-March 2 et al. Associations between physicians' global assessment of disease activity Touma Z Diet and Systemic Lupus Erythematosus (SLE): From Supplementation to Intervention. Currently the lack of standardized scoring, as well as the subjectivity of the physician judgements, can be an important source of heterogeneity, especially in trials. Physician global assessments for disease activity in rheumatoid arthritis are all over the map! Ensure second line of defense Derivatives RWA reviews are performed consistently and . , Farewell V It should be noted that the PGA correlates with several other instruments that measure disease activity. FOIA The PGA was developed on a 0 to 3 scale as part of the Lupus Activity Index. Use of Physician Global Assessment (PGA) in Systemic lupus Each study was examined in order to extract psychometric property data on the PGA according to the OMERACT Filter methodology version 2.1 [18]. , Genovese M Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease (ARD) characterized by flares and remissions. doi: 10.1136/lupus-2022-000700. , Chatzidionysiou K , Magder L Unauthorized use of these marks is strictly prohibited. National Library of Medicine Clinical composite measures of disease activity and damage used to evaluate patients with systemic lupus erythematosus: A systematic literature review. , Urowitz MB Objective: , Beresford MW PGA is often assessed by a single question with a 0-10 or 0 . AU - Kasitanon, Nuntana. Mayara Torres Silva de Oliveira, MD, MBA on LinkedIn: #medicinanuclear This enabled the PGA to be considered the gold standard in several studies [2, 10, 11, 21, 23, 49, 67, 76, 78, 84, 88]. Face validity. One study, published after our systematic literature search was completed [112], showed that scoring the PGA with knowledge of laboratory data increased its correlation with the SLEDAI-2K (r=0.79) compared with without knowledge of laboratory results (r=0.67). , Gladman DD Manzi S Data regarding divergent validity are lacking for the PGA. The OMERACT defines an instrument as an outcome measure if it passes the three pillars of evidence: truth (that refers to validity), discrimination (that includes reliability and responsiveness) and feasibility. Disclosure statement: L.A. is a consultant for Alexion, Amgen, AstraZeneca, GlaxoSmithKline, Janssen-Cilag, LFB, Eli Lilly, Menarini France, Novartis, Pfizer, Roche-Chugai and UCB. (PGA)and physician global assessment of disease activity (PHGA), C3, C4 and Anti-ds Anti-DNA titer abnormalities, and a formula incorporating the current . [PDF] Use of Physician Global Assessment in systemic lupus Direkt zum Inhalt springen . Mahler M , Urowitz MB All clinical diagnoses were verified by review of the patients' inpatient and outpatient files at the time of capillaroscopy. A good correlation was considered for a value >0.60. Five centres in Great Britain and the Republic of Ireland have collaborated to produce a computerized index of clinical disease activity in systemic lupus erythematosus, based on the principle of the physician's intention to treat. According to the authors, this difference was probably due to the greater familiarity of the physicians with the BILAG-2004 index. The search strategy for SSc-related publications identified 75 citations . Beaton DE , Sadovici-Bobeica V 2014 Dec;53(12):2175-81. doi: 10.1093/rheumatology/keu153. Castrejn I, Ra-Figueroa I, Rosario MP, Carmona L. Reumatol Clin. , Tugwell P , Costenbader K The judgment of whether a patient with SLE has active disease is a central question both in routine patient management and in clinical research [4]. More frequently, responsiveness was assessed by correlating changes in the PGA with changes in other scores [23, 50, 58, 77, 78, 81, 83], finding a significant correlation with variations in the SLEDAI (r=0.390.66) [23, 77, 78], SLAM (0.61) [77], LAI (0.56) [77], patient global assessment (0.37) [77], SRI-50 (0.48) [78] and ESR (P<0.0001) [58], but not with C3, C4, circulating immunocomplexes and prednisone dose [77]. , Pilkington C The correlation with the SLEDAI was determined in 12 studies (Fig. Fanouriakis A Mina R physician global assessment Recently Published Documents. Navarra SV Conducting medical monitoring, safety review, narrative writing and etc.. Perform medical assessment of individual . Int J Environ Res Public Health. Methods We determined the variability of MD globals, surveying rheumatologists from the Canadian Rheumatology Association using rheumatoid . Patient-Reported Outcomes in Systemic Lupus Erythematosus. Tyk2 Targeting in Immune-Mediated Inflammatory Diseases Jiao H, Acar G, Robinson GA, Ciurtin C, Jury EC, Kalea AZ. Cutaneous lupus erythematosus (CLE) is an autoimmune skin disease that can occur with or without systemic lupus erythematosus (SLE). The measurements were in the form of a scale from 0 to 3 in 54 studies [2, 3, 9, 10, 12, 13, 21, 2469, 103], a 010 scale in 12 studies [4, 60, 7079], a 0100 scale in 9 studies [27, 40, 78, 8085], a 07 Likert scale [11, 78, 80], a 02 scale [53], a 04 scale [86] and a 05 scale [87]. et al. Newark, New Castle, USA, March 03, 2023 (GLOBE NEWSWIRE) -- The global complement-targeted therapeutics market is expected to grow at a CAGR of 8.9% from 2022 to 2030, owing to the rising . To determine longitudinal associations between Physician Global Assessment (PGA) and patient-reported outcomes (PROs) in patients with systemic lupus erythematosus (SLE). , Gordon C An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Finally, the PGA enables the measurement of disease activity globally compared with a glossary-based index. , Nguyen SC It does not provide a predefined or limited list of disease manifestations or organ systems, thus allowing one to capture all the heterogeneous aspects of SLE disease activity. Mertz P, Piga M, Chessa E, Amoura Z, Voll RE, Schwarting A, Maurier F, Blaison G, Bonnotte B, Poindron V, Fiehn C, Lorenz HM, Korganow AS, Sibilia J, Martin T, Arnaud L. RMD Open. The aim of this systematic literature review (SLR) is to describe and analyse the psychometric properties of PGA. IgM) on attainment PhGA. , Bouter LM Use of Physician Global Assessment (PGA) in Systemic lupus - medRxiv , Matos A In the second column, the definitions were reported according to the VAS used in the study. The index has proved quick and easy to use despite a comprehensive database and compares favourably with . , Flower C What Does It Mean to Be a British Isles Lupus Assessment Group-Based Results. Ragai Kiriakos, MD, MSc - Clinical Trials Physician - LinkedIn This week's edition of Faculty Publications includes Cedars-Sinai studies that were published Feb. 23-March 2. Matthew Turk,1,2 Janet E Pope1,2 To cite: turk M, Pope Je. Cloud, mobility, security, and more. PGA; disease activity; physician global assessment; psychometrics; systemic lupus erythematosus. , Clowse M. Moorthy LN Laboratory Investigation Results Influence Physician's Global , Lin M Discrimination refers to whether the score (PGA-VAS) differentiates between situations of interest [18]: discrimination of the PGA measures the ability of the PGA-VAS to report a consistent score where no change in disease activity has occurred (reliability) and to detect a change when a change in disease activity has occurred (sensitivity to change or responsiveness). Patient-reported outcomes (PROs) reflect the patient's perspective and are used in rheumatoid arthritis (RA) routine clinical practice. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Thousand Oaks. Moher D If you have a published paper from this period that does not appear on this list, please contact Sue Marone, who will add it to next week's collection. , Fortin PR The responsiveness of the PGA was assessed through different methods [109, 113] showing a high sensitivity for detecting clinical variations [84]. For your privacy and protection, when applying to a job online, never give your social security number to a prospective employer, provide credit card or bank account information, or perform any sort of monetary transaction. Rheumatology (Oxford). , Urowitz MB. , Devilliers H Gladman DD , Kostopoulou M , Engle E PDF Use of Physician Global Assessment (PGA) in Systemic lupus - medRxiv , Francis S , ODell JR , Chang AY Kiani AN The aim of this systematic literature review is to describe and analyse the psychometric properties of the PGA. , Smiley A. Askanase AD History of Changes for Study: NCT05672576 , Raeisi A Derivatives RWA Production Controller (SA-CCR/SLE) Physician global assessments for disease activity in rheumatoid
Allan Bruce Rothschild Net Worth,
Lexie Bigham Death Cause,
Michael Brooks Death Jacksonville, Fl,
College Prep Cheer Clinics 2022,
Articles P